SpineGuard SA (ALSGD.PA)

EUR 0.23

(-1.09%)

Long Term Debt Summary of SpineGuard SA

  • SpineGuard SA's latest annual long term debt in 2023 was 1.87 Million EUR , down -31.22% from previous year.
  • SpineGuard SA's latest quarterly long term debt in 2024 Q2 was 1.35 Million EUR , down 0.0% from previous quarter.
  • SpineGuard SA reported annual long term debt of 2.72 Million EUR in 2022, down -21.16% from previous year.
  • SpineGuard SA reported annual long term debt of 3.45 Million EUR in 2021, up 730.63% from previous year.
  • SpineGuard SA reported quarterly long term debt of 2.25 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • SpineGuard SA reported quarterly long term debt of 1.87 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Long Term Debt Chart of SpineGuard SA (2023 - 2010)

Historical Annual Long Term Debt of SpineGuard SA (2023 - 2010)

Year Long Term Debt Long Term Debt Growth
2023 1.87 Million EUR -31.22%
2022 2.72 Million EUR -21.16%
2021 3.45 Million EUR 730.63%
2020 416.43 Thousand EUR -84.25%
2019 2.64 Million EUR -47.7%
2018 5.05 Million EUR 16.47%
2017 4.33 Million EUR -26.08%
2016 5.87 Million EUR 105.54%
2015 2.85 Million EUR 647.02%
2014 382.34 Thousand EUR -72.24%
2013 1.37 Million EUR -11.06%
2012 1.54 Million EUR 1315.29%
2011 109.43 Thousand EUR 0.0%
2010 - EUR 0.0%

Peer Long Term Debt Comparison of SpineGuard SA

Name Long Term Debt Long Term Debt Difference
Affluent Medical SA 14.41 Million EUR 86.985%
Bluelinea Société Anonyme 2.11 Million EUR 11.134%
Carmat SA 57.64 Million EUR 96.746%
Diagnostic Medical Systems S.A. 13.19 Million EUR 85.788%
Euromedis Groupe 5.08 Million EUR 63.122%
Eurobio Scientific Société anonyme 81.23 Million EUR 97.691%
Ikonisys S.A. 3.2 Million EUR 41.523%
Implanet S.A. 1.38 Million EUR -35.72%
Median Technologies SA 21.64 Million EUR 91.332%
Theraclion SA 1.95 Million EUR 3.849%
Euroapi S.A. 15.5 Million EUR 87.899%
Guerbet SA 360.51 Million EUR 99.48%
Ion Beam Applications SA 7.11 Million EUR 73.634%
Koninklijke Philips N.V. 6.17 Billion EUR 99.97%
Sequana Medical NV 8.96 Million EUR 79.087%